MCC
BBP icon

Money Concepts Capital’s Virtus Biotech ETF BBP Stock Holding History

Money Concepts Capital’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-193
Closed -$9.51K – 675
2022
Q4 		$9.51K Buy
193
+43
+29% +$2.06K ﹤0.01% 2034
2022
Q3 		$7K Sell
150
-80
-35% -$3.69K ﹤0.01% 1126
2022
Q2 		$10K Hold
230
– – ﹤0.01% 1026
2022
Q1 		$10K Buy
+230
New +$9.89K ﹤0.01% 1924

Other funds holding BBP

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $591M AUM 26.48% 1-Year Est. Return

Money Concepts Capital's BBP Position: Q1 2023 in Review

Money Concepts Capital sold out of Virtus Biotech ETF (BBP) in Q1 2023, closing a stake of 193 shares — an estimated $9.51K sold.

Money Concepts Capital first reported a position in BBP in Q1 2022 and held it in 4 quarters. The position peaked at $10K in Q2 2022. 14 funds tracked by Wall St. Rank hold BBP as of Q1 2023.

  • Money Concepts Capital reported no remaining Virtus Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 193 Virtus Biotech ETF shares in Q1 2023, an estimated $9.51K.
  • Money Concepts Capital first reported a position in Virtus Biotech ETF in Q1 2022 and held it in 4 quarters.
  • Money Concepts Capital's Virtus Biotech ETF position peaked at $10K in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.